Funder
National Key Research and Development Program of China
National Natural Science Foundation of China
the Beijing-Tianjin-Hebei basic research project
Natural Science Foundation of Tianjin Municipal Science and Technology Commission
the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences
the CAMS Innovation Fund for Medical Sciences
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. Spivak JL. Myeloproliferative neoplasms. N Engl J Med. 2017;376(22):2168–81.
2. Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management. Am J Hematol. 2017;92(1):94–108.
3. Kiladjian JJ, Giraudier S, Cassinat B. Interferon-alpha for the therapy of myeloproliferativeneoplasms: targeting the malignant clone. Leukemia. 2016;30(4):776–81.
4. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ. 2009;339:b2535.
5. Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献